federal_register: E8-4361

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
E8-4361 Draft Guidance for Industry on Drug-Induced Liver Injury: Premarketing Clinical Evaluation; Reopening of Comment Period; Public Conference Notice The Food and Drug Administration (FDA) is reopening until June 30, 2008, the comment period for the draft guidance for industry entitled "Drug-Induced Liver Injury: Premarketing Clinical Evaluation," published in the Federal Register of October 25, 2007 (72 FR 60681). FDA is also announcing a public conference entitled "Detecting and Investigating Drug-Induced Liver Injury During Clinical Trials." FDA is cosponsoring the conference with the American Association for the Study of Liver Diseases (AASLD) and the Pharmaceutical and Research Manufacturers of America. The purpose of the conference is to discuss the draft guidance and to solicit additional input on the issues and questions presented in this document. 2008-03-06 2008 3 https://www.federalregister.gov/documents/2008/03/06/E8-4361/draft-guidance-for-industry-on-drug-induced-liver-injury-premarketing-clinical-evaluation-reopening https://www.govinfo.gov/content/pkg/FR-2008-03-06/pdf/E8-4361.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is reopening until June 30, 2008, the comment period for the draft guidance for industry entitled "Drug-Induced Liver Injury: Premarketing Clinical Evaluation," published in the Federal Register of October 25,...  

Links from other tables